Search details
1.
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions.
Cell
; 185(20): 3789-3806.e17, 2022 09 29.
Article
in English
| MEDLINE | ID: mdl-36179670
2.
Divergence of mutational signatures in association with breast cancer subtype.
Mol Carcinog
; 61(11): 1056-1070, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36111610
3.
[DELAY IN DIAGNOSIS AND TREATMENT IN BREAST CANCER PATIENTS DURING THE COVID-19 PANDEMIC - CASE STUDY].
Harefuah
; 161(2): 73-76, 2022 Feb.
Article
in Hebrew
| MEDLINE | ID: mdl-35195966
4.
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Breast Cancer Res
; 22(1): 28, 2020 03 12.
Article
in English
| MEDLINE | ID: mdl-32164744
5.
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Breast Cancer Res
; 22(1): 16, 2020 02 03.
Article
in English
| MEDLINE | ID: mdl-32014063
6.
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.
Cancer Immunol Immunother
; 69(7): 1315-1326, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32198536
7.
Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.
Breast Cancer Res Treat
; 181(2): 445-453, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32303989
8.
mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues.
BMC Genomics
; 19(1): 419, 2018 May 30.
Article
in English
| MEDLINE | ID: mdl-29848287
9.
Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.
Cancer Cell
; 12(5): 432-44, 2007 Nov.
Article
in English
| MEDLINE | ID: mdl-17996647
10.
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.
Clin Cancer Res
; 30(1): 50-62, 2024 01 05.
Article
in English
| MEDLINE | ID: mdl-37939124
11.
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer.
Oncol Ther
; 11(4): 513-519, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37864026
12.
The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer.
Clin Nucl Med
; 48(3): 228-232, 2023 Mar 01.
Article
in English
| MEDLINE | ID: mdl-36638243
13.
The Role of 68 Ga-FAPI PET/CT in Breast Cancer Response Assessment and Follow-Up.
Clin Nucl Med
; 48(8): 685-688, 2023 Aug 01.
Article
in English
| MEDLINE | ID: mdl-37339456
14.
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.
NPJ Breast Cancer
; 9(1): 49, 2023 Jun 02.
Article
in English
| MEDLINE | ID: mdl-37268607
15.
Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry.
NPJ Breast Cancer
; 9(1): 79, 2023 Sep 30.
Article
in English
| MEDLINE | ID: mdl-37775723
16.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
J Clin Oncol
; 41(2): 198-205, 2023 01 10.
Article
in English
| MEDLINE | ID: mdl-36332179
17.
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol
; 41(33): 5118-5130, 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37556775
18.
Epigenetic silencing of the tumor suppressor klotho in human breast cancer.
Breast Cancer Res Treat
; 133(2): 649-57, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22042362
19.
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial.
Radiol Oncol
; 56(2): 238-247, 2022 05 17.
Article
in English
| MEDLINE | ID: mdl-35575587
20.
BREAst Cancer Personalised NuTrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy - a protocol for a randomised clinical trial.
BMJ Open
; 12(11): e062498, 2022 11 21.
Article
in English
| MEDLINE | ID: mdl-36410828